Air Date

June 23, 2020

Featured Guests

Bill Gates
Co-Chair and Trustee, Bill & Melinda Gates Foundation

Melinda Gates
Co-Chair and Trustee, Bill & Melinda Gates Foundation


The coronavirus quickly spread across the globe last winter, spurring a widespread public health emergency and subsequent economic downturn. COVID-19 was then declared a pandemic by the World Health Organization in March 2020, leading scientists and pharmaceutical companies to begin swift work on developing a vaccine. In support of these efforts, Bill and Melinda Gates of the Gates Foundation donated over $300 million in the first four months of the pandemic to facilitate research and development of safe and effective vaccines.

Nearly one year after the onset of the COVID-19 pandemic, many nations continue to grapple with its repercussions. Community outbreaks, reduced social interaction, and job insecurity have caused people significant stress and fatigue. However, there is a light at the end of the tunnel: following the initial U.S. vaccine rollout in December of 2020, production and distribution have continued to ramp up throughout the nation. In conversation with the U.S. Chamber of Commerce Foundation, Bill and Melinda Gates shared their experience and insights on vaccine development and distribution.

The Gates Foundation Focuses on Eradicating Infectious Diseases Worldwide

The Gates Foundation’s charitable donations help fund the efforts of organizations around the world to solve various problems, including public health crises.

“Our foundation has a big focus on infectious diseases that kill millions of people, primarily in developing countries. And so in our understanding about how you design a vaccine, we’ve funded lots of new vaccines,” explained Bill Gates. “We’re a partner in Gavi, [an organization] which actually buys vaccines for developing countries.”

“We have a lot of expertise that’s not in the private sector to pick which of these we should build factories for and how we coordinate all this activity,” Bill added. “And so [vaccine development and distribution] has become a huge focus for us.”

Bill and Melinda Gates Optimistic About the COVID-19 Vaccine

Even in June of 2020, Melinda Gates had every reason for optimism: “I think we all believe that by 2021, we will have a vaccine.”

“We’re working ahead of time with… the manufacturers, with pharmaceutical companies, to try and actually have manufacturing capability ready to go,” Melinda Gates added. “So as soon as those trials are finished, the vaccine can go immediately into manufacturing.”

“The benefit of getting the vaccine even three or four months earlier will be very dramatic in terms of ending these awful economic effects, as well as the death and disease," stressed Bill Gates.